本文へスキップ

相互作用

Atezolizumab + Siponimod

重症度: 中等度

Atezolizumab and Siponimod: moderate interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Atezolizumab enhances immune activity by blocking PD-L1, and siponimod reduces circulating lymphocytes, so the two act in opposing directions. Siponimod could weaken the antitumour effect of atezolizumab, and the combination might alter the risk of immune-related adverse events in unpredictable ways.

この相互作用をわかりやすく説明すると

Atezolizumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Atezolizumab belongs to Oncology; Siponimod belongs to Central Nervous System.

エビデンスレベル: Low

なぜ起こるのか

Pharmacodynamic opposition between lymphocyte sequestration by siponimod and T-cell reactivation by PD-L1 blockade; not well characterised clinically.

対処法

Avoid starting siponimod in patients receiving checkpoint inhibitors unless clearly needed; monitor lymphocyte counts, infection and immune-related adverse events.

薬剤師に尋ねること

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、AtezolizumabとSiponimodの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を14日間無料でお試し。カード登録不要。

よくある質問

Can I take Atezolizumab with Siponimod?

MediHelp rates the interaction as moderate. Atezolizumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Atezolizumab enhances immune activity by blocking PD-L1, and siponimod reduces circulating lymphocytes, so the two act in opposing directions. Siponimod could weaken the antitumour effect of atezolizumab, and the combination might alter the risk of immune-related adverse events in unpredictable ways.

How serious is the interaction between Atezolizumab and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting siponimod in patients receiving checkpoint inhibitors unless clearly needed; monitor lymphocyte counts, infection and immune-related adverse events.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン